The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic stem cell therapy is 100% safe, which further supports its demand on a global level. Pet owners are identified to prefer allogeneic stem cell therapy over autologous therapy, attributed to its relatively lower costs and comparative ease of the entire procedure.
A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry.
Market Analysis and Insights: Global Canine Stem Cell Therapy Market
The global Canine Stem Cell Therapy market size is projected to reach US$ 119.4 million by 2026, from US$ 103.4 million in 2020, at a CAGR of 2.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Canine Stem Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Canine Stem Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Canine Stem Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Canine Stem Cell Therapy market.
Canine Stem Cell Therapy Breakdown Data by Type
Allogeneic Stem Cells
Autologous Stem cells
Canine Stem Cell Therapy Breakdown Data by Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes
Based on regional and country-level analysis, the Canine Stem Cell Therapy market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Canine Stem Cell Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
VETSTEM BIOPHARMA
Cell Therapy Sciences
Regeneus
Aratana Therapeutics
Medivet Biologics
Okyanos
Vetbiologics
VetMatrix
Magellan Stem Cells
ANIMAL CELL THERAPIES
Stemcellvet
A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry.
Market Analysis and Insights: Global Canine Stem Cell Therapy Market
The global Canine Stem Cell Therapy market size is projected to reach US$ 119.4 million by 2026, from US$ 103.4 million in 2020, at a CAGR of 2.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Canine Stem Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Canine Stem Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Canine Stem Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Canine Stem Cell Therapy market.
Canine Stem Cell Therapy Breakdown Data by Type
Allogeneic Stem Cells
Autologous Stem cells
Canine Stem Cell Therapy Breakdown Data by Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes
Based on regional and country-level analysis, the Canine Stem Cell Therapy market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Canine Stem Cell Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
VETSTEM BIOPHARMA
Cell Therapy Sciences
Regeneus
Aratana Therapeutics
Medivet Biologics
Okyanos
Vetbiologics
VetMatrix
Magellan Stem Cells
ANIMAL CELL THERAPIES
Stemcellvet
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Stem Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Allogeneic Stem Cells
1.2.3 Autologous Stem cells
1.3 Market by Application
1.3.1 Global Canine Stem Cell Therapy Market Share by Application: 2020 VS 2026
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Veterinary Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Canine Stem Cell Therapy Market Perspective (2015-2026)
2.2 Global Canine Stem Cell Therapy Growth Trends by Regions
2.2.1 Canine Stem Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Canine Stem Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Canine Stem Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Canine Stem Cell Therapy Players by Market Size
3.1.1 Global Top Canine Stem Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global Canine Stem Cell Therapy Revenue Market Share by Players (2015-2020)
3.2 Global Canine Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Canine Stem Cell Therapy Revenue
3.4 Global Canine Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Canine Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Stem Cell Therapy Revenue in 2019
3.5 Key Players Canine Stem Cell Therapy Area Served
3.6 Key Players Canine Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Canine Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Canine Stem Cell Therapy Breakdown Data by Type (2015-2026)
4.1 Global Canine Stem Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Canine Stem Cell Therapy Forecasted Market Size by Type (2021-2026)
5 Canine Stem Cell Therapy Breakdown Data by Application (2015-2026)
5.1 Global Canine Stem Cell Therapy Historic Market Size by Application (2015-2020)
5.2 Global Canine Stem Cell Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Canine Stem Cell Therapy Market Size (2015-2026)
6.2 North America Canine Stem Cell Therapy Market Size by Type (2015-2020)
6.3 North America Canine Stem Cell Therapy Market Size by Application (2015-2020)
6.4 North America Canine Stem Cell Therapy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Canine Stem Cell Therapy Market Size (2015-2026)
7.2 Europe Canine Stem Cell Therapy Market Size by Type (2015-2020)
7.3 Europe Canine Stem Cell Therapy Market Size by Application (2015-2020)
7.4 Europe Canine Stem Cell Therapy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Canine Stem Cell Therapy Market Size (2015-2026)
8.2 China Canine Stem Cell Therapy Market Size by Type (2015-2020)
8.3 China Canine Stem Cell Therapy Market Size by Application (2015-2020)
8.4 China Canine Stem Cell Therapy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Canine Stem Cell Therapy Market Size (2015-2026)
9.2 Japan Canine Stem Cell Therapy Market Size by Type (2015-2020)
9.3 Japan Canine Stem Cell Therapy Market Size by Application (2015-2020)
9.4 Japan Canine Stem Cell Therapy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Canine Stem Cell Therapy Market Size (2015-2026)
10.2 Southeast Asia Canine Stem Cell Therapy Market Size by Type (2015-2020)
10.3 Southeast Asia Canine Stem Cell Therapy Market Size by Application (2015-2020)
10.4 Southeast Asia Canine Stem Cell Therapy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 VETSTEM BIOPHARMA
11.1.1 VETSTEM BIOPHARMA Company Details
11.1.2 VETSTEM BIOPHARMA Business Overview
11.1.3 VETSTEM BIOPHARMA Canine Stem Cell Therapy Introduction
11.1.4 VETSTEM BIOPHARMA Revenue in Canine Stem Cell Therapy Business (2015-2020))
11.1.5 VETSTEM BIOPHARMA Recent Development
11.2 Cell Therapy Sciences
11.2.1 Cell Therapy Sciences Company Details
11.2.2 Cell Therapy Sciences Business Overview
11.2.3 Cell Therapy Sciences Canine Stem Cell Therapy Introduction
11.2.4 Cell Therapy Sciences Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.2.5 Cell Therapy Sciences Recent Development
11.3 Regeneus
11.3.1 Regeneus Company Details
11.3.2 Regeneus Business Overview
11.3.3 Regeneus Canine Stem Cell Therapy Introduction
11.3.4 Regeneus Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.3.5 Regeneus Recent Development
11.4 Aratana Therapeutics
11.4.1 Aratana Therapeutics Company Details
11.4.2 Aratana Therapeutics Business Overview
11.4.3 Aratana Therapeutics Canine Stem Cell Therapy Introduction
11.4.4 Aratana Therapeutics Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.4.5 Aratana Therapeutics Recent Development
11.5 Medivet Biologics
11.5.1 Medivet Biologics Company Details
11.5.2 Medivet Biologics Business Overview
11.5.3 Medivet Biologics Canine Stem Cell Therapy Introduction
11.5.4 Medivet Biologics Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.5.5 Medivet Biologics Recent Development
11.6 Okyanos
11.6.1 Okyanos Company Details
11.6.2 Okyanos Business Overview
11.6.3 Okyanos Canine Stem Cell Therapy Introduction
11.6.4 Okyanos Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.6.5 Okyanos Recent Development
11.7 Vetbiologics
11.7.1 Vetbiologics Company Details
11.7.2 Vetbiologics Business Overview
11.7.3 Vetbiologics Canine Stem Cell Therapy Introduction
11.7.4 Vetbiologics Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.7.5 Vetbiologics Recent Development
11.8 VetMatrix
11.8.1 VetMatrix Company Details
11.8.2 VetMatrix Business Overview
11.8.3 VetMatrix Canine Stem Cell Therapy Introduction
11.8.4 VetMatrix Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.8.5 VetMatrix Recent Development
11.9 Magellan Stem Cells
11.9.1 Magellan Stem Cells Company Details
11.9.2 Magellan Stem Cells Business Overview
11.9.3 Magellan Stem Cells Canine Stem Cell Therapy Introduction
11.9.4 Magellan Stem Cells Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.9.5 Magellan Stem Cells Recent Development
11.10 ANIMAL CELL THERAPIES
11.10.1 ANIMAL CELL THERAPIES Company Details
11.10.2 ANIMAL CELL THERAPIES Business Overview
11.10.3 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Introduction
11.10.4 ANIMAL CELL THERAPIES Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.10.5 ANIMAL CELL THERAPIES Recent Development
11.11 Stemcellvet
10.11.1 Stemcellvet Company Details
10.11.2 Stemcellvet Business Overview
10.11.3 Stemcellvet Canine Stem Cell Therapy Introduction
10.11.4 Stemcellvet Revenue in Canine Stem Cell Therapy Business (2015-2020)
10.11.5 Stemcellvet Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Stem Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Allogeneic Stem Cells
1.2.3 Autologous Stem cells
1.3 Market by Application
1.3.1 Global Canine Stem Cell Therapy Market Share by Application: 2020 VS 2026
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Veterinary Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Canine Stem Cell Therapy Market Perspective (2015-2026)
2.2 Global Canine Stem Cell Therapy Growth Trends by Regions
2.2.1 Canine Stem Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Canine Stem Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Canine Stem Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Canine Stem Cell Therapy Players by Market Size
3.1.1 Global Top Canine Stem Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global Canine Stem Cell Therapy Revenue Market Share by Players (2015-2020)
3.2 Global Canine Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Canine Stem Cell Therapy Revenue
3.4 Global Canine Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Canine Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Stem Cell Therapy Revenue in 2019
3.5 Key Players Canine Stem Cell Therapy Area Served
3.6 Key Players Canine Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Canine Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Canine Stem Cell Therapy Breakdown Data by Type (2015-2026)
4.1 Global Canine Stem Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Canine Stem Cell Therapy Forecasted Market Size by Type (2021-2026)
5 Canine Stem Cell Therapy Breakdown Data by Application (2015-2026)
5.1 Global Canine Stem Cell Therapy Historic Market Size by Application (2015-2020)
5.2 Global Canine Stem Cell Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Canine Stem Cell Therapy Market Size (2015-2026)
6.2 North America Canine Stem Cell Therapy Market Size by Type (2015-2020)
6.3 North America Canine Stem Cell Therapy Market Size by Application (2015-2020)
6.4 North America Canine Stem Cell Therapy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Canine Stem Cell Therapy Market Size (2015-2026)
7.2 Europe Canine Stem Cell Therapy Market Size by Type (2015-2020)
7.3 Europe Canine Stem Cell Therapy Market Size by Application (2015-2020)
7.4 Europe Canine Stem Cell Therapy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Canine Stem Cell Therapy Market Size (2015-2026)
8.2 China Canine Stem Cell Therapy Market Size by Type (2015-2020)
8.3 China Canine Stem Cell Therapy Market Size by Application (2015-2020)
8.4 China Canine Stem Cell Therapy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Canine Stem Cell Therapy Market Size (2015-2026)
9.2 Japan Canine Stem Cell Therapy Market Size by Type (2015-2020)
9.3 Japan Canine Stem Cell Therapy Market Size by Application (2015-2020)
9.4 Japan Canine Stem Cell Therapy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Canine Stem Cell Therapy Market Size (2015-2026)
10.2 Southeast Asia Canine Stem Cell Therapy Market Size by Type (2015-2020)
10.3 Southeast Asia Canine Stem Cell Therapy Market Size by Application (2015-2020)
10.4 Southeast Asia Canine Stem Cell Therapy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 VETSTEM BIOPHARMA
11.1.1 VETSTEM BIOPHARMA Company Details
11.1.2 VETSTEM BIOPHARMA Business Overview
11.1.3 VETSTEM BIOPHARMA Canine Stem Cell Therapy Introduction
11.1.4 VETSTEM BIOPHARMA Revenue in Canine Stem Cell Therapy Business (2015-2020))
11.1.5 VETSTEM BIOPHARMA Recent Development
11.2 Cell Therapy Sciences
11.2.1 Cell Therapy Sciences Company Details
11.2.2 Cell Therapy Sciences Business Overview
11.2.3 Cell Therapy Sciences Canine Stem Cell Therapy Introduction
11.2.4 Cell Therapy Sciences Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.2.5 Cell Therapy Sciences Recent Development
11.3 Regeneus
11.3.1 Regeneus Company Details
11.3.2 Regeneus Business Overview
11.3.3 Regeneus Canine Stem Cell Therapy Introduction
11.3.4 Regeneus Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.3.5 Regeneus Recent Development
11.4 Aratana Therapeutics
11.4.1 Aratana Therapeutics Company Details
11.4.2 Aratana Therapeutics Business Overview
11.4.3 Aratana Therapeutics Canine Stem Cell Therapy Introduction
11.4.4 Aratana Therapeutics Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.4.5 Aratana Therapeutics Recent Development
11.5 Medivet Biologics
11.5.1 Medivet Biologics Company Details
11.5.2 Medivet Biologics Business Overview
11.5.3 Medivet Biologics Canine Stem Cell Therapy Introduction
11.5.4 Medivet Biologics Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.5.5 Medivet Biologics Recent Development
11.6 Okyanos
11.6.1 Okyanos Company Details
11.6.2 Okyanos Business Overview
11.6.3 Okyanos Canine Stem Cell Therapy Introduction
11.6.4 Okyanos Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.6.5 Okyanos Recent Development
11.7 Vetbiologics
11.7.1 Vetbiologics Company Details
11.7.2 Vetbiologics Business Overview
11.7.3 Vetbiologics Canine Stem Cell Therapy Introduction
11.7.4 Vetbiologics Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.7.5 Vetbiologics Recent Development
11.8 VetMatrix
11.8.1 VetMatrix Company Details
11.8.2 VetMatrix Business Overview
11.8.3 VetMatrix Canine Stem Cell Therapy Introduction
11.8.4 VetMatrix Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.8.5 VetMatrix Recent Development
11.9 Magellan Stem Cells
11.9.1 Magellan Stem Cells Company Details
11.9.2 Magellan Stem Cells Business Overview
11.9.3 Magellan Stem Cells Canine Stem Cell Therapy Introduction
11.9.4 Magellan Stem Cells Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.9.5 Magellan Stem Cells Recent Development
11.10 ANIMAL CELL THERAPIES
11.10.1 ANIMAL CELL THERAPIES Company Details
11.10.2 ANIMAL CELL THERAPIES Business Overview
11.10.3 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Introduction
11.10.4 ANIMAL CELL THERAPIES Revenue in Canine Stem Cell Therapy Business (2015-2020)
11.10.5 ANIMAL CELL THERAPIES Recent Development
11.11 Stemcellvet
10.11.1 Stemcellvet Company Details
10.11.2 Stemcellvet Business Overview
10.11.3 Stemcellvet Canine Stem Cell Therapy Introduction
10.11.4 Stemcellvet Revenue in Canine Stem Cell Therapy Business (2015-2020)
10.11.5 Stemcellvet Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
